Documents & Downloads

Taprizosin mesylate

α-Adrenoreceptor Antagonist

Taprizosin mesylate is an α-adrenoreceptor antagonist that selectively inhibits α1-adrenoreceptors, influencing vascular smooth muscle contraction. This compound is primarily utilized in research focused on cardiovascular pharmacology and hypertension, allowing for the investigation of adrenergic signaling pathways and receptor interactions. Its specific activity makes it a valuable tool for studying the role of α-adrenoceptors in various biological processes.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Antagonist
CAS Number	358632-25-4
Applications	α-Adrenoreceptor Antagonist
Formula	C₂₆H₃₀N₆O₇S₂
Molecular Weight	602.68
Synonyms	UK-338003 mesylate
SMILES	CS(=O)(NC1=CC=CC2=C1CCN(C3=NC(N)=C4C(C5=NC=CC=C5)=C(OC)C(OC)=CC4=N3)C2)=O.CS(=O)(O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.